Suchergebnisse - "De Novellis, Danilo"

PubPharm (22)

1

Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients

enthalten in: Cancer reports (Hoboken, N.J.) | 2024

von Serio, B. | Grimaldi, F. | Ammirati, L. | +11

2

Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B

enthalten in: Photodermatology, photoimmunology & photomedicine | 2024

von De Novellis, D. | Raimondo, A. | Serio, B. | +4

3

Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors : A Real-Life Experience

enthalten in: Hematology reports | 2024

von Serio, B. | Storti, G. | D'Addona, M. | +17

4

Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies

enthalten in: Clinical and experimental medicine | 2024

von Ianniello, M. | De Novellis, D. | Pezzullo, L. | +13

5

Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies

enthalten in: Clinical and experimental medicine | 2024

von Giudice, V. | Ianniello, M. | De Novellis, D. | +14

6

Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients

enthalten in: Cancer Reports | 2024

von Serio, B. | Grimaldi, F. | Ammirati, L. | +11

7

Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients

enthalten in: Clinical and experimental medicine | 2023

von De Novellis, D. | Folliero, V. | Giudice, V. | +21

8

Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders : A Multicenter Real-Life Experience

enthalten in: Targeted oncology | 2023

von De Novellis, D. | Fontana, R. | Palmieri, S. | +30

9

Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition

enthalten in: European journal of haematology | 2023

von Giudice, V. | Serio, B. | Errichiello, S. | +14

10

Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients

enthalten in: Clinical and experimental medicine | 2023

von De Novellis, D. | Folliero, V. | Giudice, V. | +21